Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Michael O. Falster"'
Autor:
Juliana de Oliveira Costa, Sallie-Anne Pearson, David Brieger, Sanja Lujic, Md Shajedur Rahman Shawon, Louisa R. Jorm, Kees van Gool, Michael O. Falster
Publikováno v:
International Journal for Equity in Health, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background International evidence suggests patients receiving cardiac interventions experience differential outcomes by their insurance status. We investigated outcomes of in-hospital care according to insurance status among patients admitte
Externí odkaz:
https://doaj.org/article/7c66ae2721bc4cef9271af5bc2e32730
Autor:
Juliana de Oliveira Costa, Jialing Lin, Sallie‐Anne Pearson, Nicholas A. Buckley, Andrea L. Schaffer, Michael O. Falster
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 13 (2023)
Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia. Method
Externí odkaz:
https://doaj.org/article/3986dcbf6c4b4ab5804306c058f9bc2d
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract We quantified the interaction of multimorbidity and frailty and their impact on adverse health outcomes in the hospital setting. Using aretrospective cohort study of persons aged ≥ 75 years, admitted to hospital during 2010–2012 in New S
Externí odkaz:
https://doaj.org/article/45eee06d66994b15af52716327f63c50
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 16, Iss 1, Pp 1-15 (2021)
Abstract Background Readmission after coronary artery bypass graft (CABG) surgery is associated with adverse outcomes and significant healthcare costs, and 30-day readmission rate is considered as a key indicator of the quality of care. This study ai
Externí odkaz:
https://doaj.org/article/f1b1c207183048cf8ccbd132146ef555
Autor:
Andrea L. Schaffer, Michael O. Falster, David Brieger, Louisa R. Jorm, Andrew Wilson, Melanie Hay, Kira Leeb, Sallie Pearson, Arthur Nasis
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 24 (2019)
Background Oral anticoagulant (OAC) therapy reduces the risk of stroke in people with atrial fibrillation (AF), and is considered best practice; however, there is little Australian evidence around the uptake of OACs in this population. Methods and Re
Externí odkaz:
https://doaj.org/article/1c41edaf4a3a42e7bb91a0825221cb86
Autor:
Holger Möller, Kathleen Falster, Rebecca Ivers, Michael O. Falster, Kathleen Clapham, Louisa Jorm
Publikováno v:
Australian and New Zealand Journal of Public Health, Vol 41, Iss 1, Pp 8-14 (2017)
Abstract Objective: To describe the leading mechanisms of hospitalised unintentional injury in Australian Aboriginal children and identify the injury mechanisms with the largest inequalities between Aboriginal and non‐Aboriginal children. Methods:
Externí odkaz:
https://doaj.org/article/137cd2a035c04a888fb619ca20131917
Publikováno v:
Australian and New Zealand Journal of Public Health, Vol 38, Iss 1, Pp 30-34 (2014)
Abstract Objective: To quantify the risk of incident cancer and cancer‐related mortality in Australian Government Department of Veterans’ Affairs (DVA) clients. Methods: A population‐based record linkage study of 75,482 adult clients residing i
Externí odkaz:
https://doaj.org/article/4c513fff5d4b47249cd79603f3a445f7
Autor:
Md Shajedur Rahman Shawon, Michael O. Falster, Benjumin Hsu, Jennifer Yu, Sze-Yuan Ooi, Louisa Jorm
Publikováno v:
The American Journal of Cardiology. 187:110-118
Risk profiles are changing for patients who undergo percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). In Australia, little is known of the nature of these changes in contemporary practice and of the impact on patien
A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 42:828-836
Multimorbidity and multimedicine use are common in people with cardiovascular disease and can lead to harms, such as prescribing errors and drug interactions. We quantified multimedicine use in people treated with cardiovascular medicines in a nation
Autor:
Juan C. Quiroz, David Brieger, Louisa R. Jorm, Raymond W. Sy, Michael O. Falster, Blanca Gallego
Publikováno v:
Heart, Lung and Circulation. 31:1269-1276
To investigate clinical and health system factors associated with receiving catheter ablation (CA) and earlier ablation for non-valvular atrial fibrillation (AF).We used hospital administrative data linked with death registrations in New South Wales,